A Multi Center Double Blind Randomized Placebo Controlled Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg day, 400mg day, 600 mg day) as Adjunctive Therapy in Subjects with Partial Seizures

  • Fakhoury, Toufic (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date12/15/0310/31/11